LIOR Pupillometry Inc.

What LIOR Pupillometry Inc. does

LIOR Pupillometry Inc. is a privately-held Canadian medical device company headquartered in Woodbridge, Ontario, developing a handheld digital pupillometer for objective neurological assessment in clinical and pre-hospital settings. The company's flagship product, the LIOR™ pupillometer, captures pupil size and reactivity in seconds using infrared imaging, LED indicators, and a single-button "Click, Point, Shoot" workflow, with a proprietary PLR-3 Algorithm (currently at version 6) reported to deliver 95% accuracy across 50,000 AI-simulated conditions. The device is intended for Emergency Medical Services, emergency department triage, intensive care and neurocritical care monitoring, toxicology, remote/low-resource settings, and medical training.

The underlying technology combines a custom printed circuit board integrating infrared sensing and LED arrays, a privacy-preserving on-device architecture (no data retained beyond reset), and a three-light output system (green/yellow/red) translating pupil reactivity into instant clinical decision signals. Hardware differentiators include a rotational bezel with sighting mechanism and red focus ring for positioning accuracy, and a dual-mode flashlight/pupillometer toggle. The company has filed a pending patent package covering the device and PLR-3 Algorithm and is pursuing a defined regulatory pathway for medical device clearance; no certifications, funding rounds, named customers, or commercial revenue have been disclosed.

The business model is hardware sales to healthcare institutions (EMS services, hospitals, ICU departments) combined with collaboration and pilot-program engagement, supported by a direct sales motion complemented by medical-conference/event exposure and planned medical device channel partner distribution. Pricing is not publicly disclosed and is contact-based. LIOR is at a pre-commercial/validation stage; the company has not yet announced regulatory clearance, institutional customers, or external financing.

Name

LIOR Pupillometry Inc.

Legal name

LIOR Pupillometry Inc.

Website

https://liorpupillometry.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

LIOR Pupillometry Inc. is a Canadian medical device company developing a handheld digital pupillometer with a proprietary PLR-3 Algorithm for rapid, objective pupil assessment in EMS, ER, ICU, toxicology, remote, and medical training settings, currently at pre-commercial validation stage.

Ownership category

akta.pro rank

Product category

Medical Devices (Neurological Diagnostics)

NAICS

Other Measuring and Controlling Device Manufacturing (334519), Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals (334515)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Ophthalmic Goods (3851), Instruments For Meas & Testing Of Electricity & Elec Signals (3825)

akta.pro industry

PRIMARYHLAHAJAC

Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)

SECONDARYHLAHAJAN

Low Vision & Assistive Vision Devices (Magnifiers, Electronic Video Magnifiers, Wearable Vision Aids)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)

Keywords

• Digital pupillometry devices
• Neurological assessment tools
• Handheld medical diagnostics
• Infrared pupil measurement
• Critical care monitoring

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Device Hardware Sales: LIOR is a handheld medical device that will generate revenue through hardware sales to healthcare institutions including EMS services, emergency rooms, and ICU departments. The company is in pre-commercial/validation stage.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

LIOR Pupillometry Inc. develops and manufactures a handheld digital pupillometer that captures pupil size and reactivity in seconds using infrared imaging, LED indicators, and a proprietary PLR-3 Algorithm. The device is designed for objective neurological assessment in EMS, ER, ICU, and neurocritical care settings, replacing subjective manual penlight examinations with standardized digital measurement. The company is currently in pre-commercial/validation stage.

Product overview

LIOR Pupillometry Inc. offers a single unified product: the LIOR™ handheld digital pupillometer, which combines specialized hardware with the proprietary PLR-3 Algorithm. The device captures pupil size and reactivity using infrared imaging and LED indicators in seconds, designed for use in EMS, ER, ICU, and Neurocritical Care settings. The PLR-3 Algorithm is embedded in the device firmware, providing standardized three-light output (green/yellow/red) for instant assessment results.

Differentiator

Problem solved

Functional benefit

Brands

• LIOR™: Handheld digital pupilometer for EMS, ER, and Neurocritical Care that captures pupil size and reactivity in seconds using infrared imaging, LED indicators, and a single-button interface.
• PLR-3 Algorithm

Products and services

• LIOR Pupillometry Portable Digital Pupillometer A handheld digital pupillometer for EMS, ER, and Neurocritical Care clinicians that captures pupil size and reactivity in seconds using infrared imaging, LED indicators, and a single-button interface. Features a 'Click, Point, Shoot' workflow with green/yellow/red three-light output for instant assessment.

Quantifiable outcome

• 95% overall accuracy in pupil diameter and reactivity measurements (validated through 50,000 AI simulated conditions)
• +1 more outcomes

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Others

• NovaBay Pharmaceuticals: Ophthalmic-focused specialty pharmaceutical company. Comparable only thematically as another small-cap, ophthalmic-adjacent healthcare company, but not a direct competitor to pupillometry hardware.

Broad incumbents

• Natus Medical: Established neurodiagnostic and newborn screening device manufacturer. Comparable as a broader incumbent offering overlapping neurological assessment tools (including neuro ICU monitoring) to similar hospital buyers.
• Masimo: Global patient monitoring and pulse oximetry leader with expanding neurological/cerebral monitoring portfolio. Comparable as a large incumbent selling into ICU and ER with overlapping monitoring workflows and procurement relationships.
• Compumedics: Australian medical device company specializing in neurological and sleep diagnostics. Comparable as an adjacent neurodiagnostic device vendor serving hospitals with overlapping clinical decision-maker buyers.

Emerging players

• iHealthScreen: AI-based ophthalmic screening company using computer vision for eye disease detection. Comparable as a vision-focused AI/digital health player leveraging imaging and algorithms for clinical assessment, though at different stages and use cases.
• Brightlamp: Digital health company developing smartphone-based pupillometry and concussion assessment tools. Comparable as an emerging entrant in objective pupil measurement with a different form factor and go-to-market approach.

Direct peers

• IDMED: French medical device company producing the AlgiScan and video pupillometers used in anesthesia and critical care. Directly competes in quantitative pupillometry with comparable target customers and use cases.
• NeurOptics: Market-leading quantitative pupillometry device maker (NPi series) widely used in ICUs and ERs. Directly comparable to LIOR as both target the same clinical workflow of objective pupil measurement for neurological assessment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/lior-pupillometry

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LIOR Pupillometry Inc.